ロード中...
Whole‐Genome mRNA Expression Profiling Identifies Functional and Prognostic Signatures in Patients with Mesenchymal Glioblastoma Multiforme
BACKGROUND: The Cancer Genome Atlas (TCGA) has divided patients with glioblastoma multiforme (GBM) into four subtypes based on mRNA expression microarray. The mesenchymal subtype, with a larger proportion, is considered a more lethal one. Clinical outcome prediction is required to better guide more...
保存先:
| 出版年: | CNS Neurosci Ther |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6493663/ https://ncbi.nlm.nih.gov/pubmed/23663361 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12118 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|